Skip to content
Screener

Albemarle ALB Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Lithium Americas logo
Lithium AmericasLAC
$532.93M+72.2%
Westlake logo
WestlakeWLK
$503M-1.9%
Atlas Lithium Corporation logo
Atlas Lithium CorporationATLX
$7.3M+1,014%
Eastman Chemical logo
Eastman ChemicalEMN
$77M+5.5%
Cabot Corporation logo
Cabot CorporationCBT
$119M-27.0%
Element Solutions logo
Element SolutionsESI
$14.6M-3.3%

Other financials

Income statement

See full
Revenue$1.7B+31.1%
Gross profit$590.3M+200%
Operating income$452.9M+853%
Net income$480.0M+1,996%
EPS (diluted)$3.52+2,300%

Balance sheet

See full
Cash & equivalents$1.6B-9.7%
Total debt$2.1B-45.5%
Total equity$10.3B+0.3%
Total assets$15.9B-8.0%

Cash flow

See full
Operating cash flow$710.0M
CapEx$71.7M-40.0%
Free cash flow$638.3M

Valuation

See full
Market cap$15.47B+74.2%
Enterprise value$15.94B+45.7%
P/E69×
P/S2.6×+0.8×

Profitability

See full
Gross margin23.8%+16.1pp
Operating margin4.3%+2.3pp
Net margin3.8%+2.1pp
FCF margin22.7%

Returns & leverage

See full
Return on equity2.2%+1.2pp
Debt / equity0.2×-0.2×
Current ratio2.1×-0.2×

Where this comes from

Reported directly by Albemarle in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Albemarle’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:40 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000915913-26-000102
Line itemJune 30, 2026December 31, 2025
Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized – 15,000, issued and outstanding – 2,300 in 2026 and 20252,235,1052,235,105
Additional paid-in capital3,048,6643,018,213
Accumulated other comprehensive loss(243,599)(334,807)
Retained earnings5,233,8194,613,676
Total Albemarle Corporation shareholders’ equity10,275,1699,533,365
Noncontrolling interests258,685248,096
Total equity10,533,8549,781,461
Total liabilities and equity$15,905,095$16,374,211

Item 1. Financial Statements (Unaudited).

FAQ

What is Albemarle's noncontrolling interests in subsidiaries?
Albemarle (ALB) reported noncontrolling interests in subsidiaries of $258.69M in Q2 2026.
How has Albemarle's noncontrolling interests in subsidiaries changed year-over-year?
Albemarle's noncontrolling interests in subsidiaries increased by 0.1% year-over-year, from $258.46M to $258.69M.
What is the long-term trend for Albemarle's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), Albemarle's noncontrolling interests in subsidiaries has grown at a 4.4% compound annual growth rate (CAGR), from $200.37M to $248.1M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Albemarle's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude